Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.

Launched by ISABEL MORENO HAY · Nov 17, 2021

Keywords

ClinConnect Summary

Participants were recruited consecutively from patients referred by a board certified sleep physician to the Orofacial Pain Clinic (University of Kentucky, Lexington, Kentucky, USA) for the management of OSA with a mandibular advancement device. An NOA® appliance (Orthoapnea S.L., Malaga, Spain) was custom made for each participant. Digital impressions (scanner 3Shape TRIOS® 3, Copenhagen, Denmark), protrusive records at 50% from maximum protrusion (using a 5 mm fork and George GaugeTM, Great Lakes Dental Technologies, Tonawanda, NY, USA), and clinical pictures were obtained following the p...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: \>18 and \<80 years old.
• • No history of previous use of a MAD.
• • Diagnosis of OSA by a sleep physician based on a PSG or HSAT (done \>12 months before evaluation date or \> 12 months with \>10% variation of BMI).
• • Upon clinical examination: \>8 teeth per arch; range of anteroposterior mandibular mobility \>5 mm.
• • Informed consent to participate in the study.
• Exclusion Criteria:
• • Patients with concomitant diagnosed sleep disorders (i.e. insomnia, narcolepsy, restless legs syndrome, rapid eye movement sleep behavior disorder).
• • History of previous allergic reaction to the appliance material (Polyamide 12).
• • Patients using combination therapy for the management of OSA (i.e. PAP therapy or positional therapy).
• • Upon clinical examination: periodontal disease (\>4 mm on periodontal probing, with bleeding on probing, visual signs of periodontal inflammation); tooth horizontal mobility \>1 mm, vertical mobility, and unfavorable crown to root ratio; open cavities, loose or fractured restorations, or patient undergoing restorative dental treatments.
• • Exaggerated gag reflex.
• • Lack of coordination or dexterity.
• • Inadequate English comprehension.